Clinical Trials Logo

Clinical Trial Summary

Traditional ureteral stents are commonly used in renal and ureteral procedures, and their use is associated with many morbidities which can affect patients' quality of life. However, replacement of the distal portion of the stent with a thin material may reduce bladder irritative symptoms and allow the ureterovesical junction to coapt---thereby, reducing urinary reflux. The hypothesis is that the RELIEF stent will offer the same function of traditional ureteral stents with the added benefits of minimizing urinary reflux and reducing irritative bladder symptoms.


Clinical Trial Description

Traditional ureteral stents are commonly used in practice to relieve renal obstruction or as a scaffold to promote healing after endoscopic or open/ laparoscopic surgeries involving the ureter. However, there are many morbidities associated with stent placement either due to bladder irritation or backflow of urine to the kidney. The most commonly reported symptoms include urgency, urinary frequency, dysuria, incontinence, hematuria, suprapubic discomfort, and fever due to urinary tract infections and flank pain, which can occur in up to 80% of stented patients. Sometimes, the symptoms are poorly tolerated and can negatively affect patients' quality of life. Shao et al have studied the relationship between bladder filling and the renal pelvic pressure (RPP) in stented patients, which revealed that RPP increased mildly during bladder filling and increased dramatically during voiding, indicating urinary reflux, and thus encouraging early stent removal. Another study showed that patients with stents whose distal coils cross the midline are at higher risk of post-stenting morbidities. Replacement of the distal portion of the ureteral stent with a thin material may reduce bladder irritative symptoms and allow the ureterovesical junction to coapt, thereby eliminating urinary reflux. The Ureteral Stent Company, LLC (USC) is developing the RELIEF™ Ureteral Stent, a single use, disposable ureteral stent (US) device that will provide the traditional function of allowing the passage of urine from the kidney to the bladder with new design enhancements to improve patient care: - A low-profile tether through the intramural ureter segment, minimizing the potential of urinary reflux - Polymeric solid distal coil that minimizes the potential for coil positioning on the trigone, reducing the potential for associated bladder spasms and pain. It is hypothesized that the RELIEF stent will offer the same function of traditional ureteral stents with the added benefits of minimizing the urinary reflux and reducing irritative bladder symptoms. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03266770
Study type Interventional
Source University Hospitals Cleveland Medical Center
Contact
Status Completed
Phase N/A
Start date June 15, 2021
Completion date December 12, 2022

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06110299 - Room Air a Safe Alternative to Dye Injection in Ureterography N/A
Completed NCT01741454 - Treatment of Symptoms After Stent Placement for Urinary Tract Obstruction Phase 4
Completed NCT00790686 - Tolerance and Effectiveness of Ureteral Stents MEMOKATH ® 051 in Chronic Strictures of the Ureter Phase 2
Completed NCT00568724 - Urinary Biomarkers as Predictors on Renal Function in Congenital Hydronephrosis N/A
Completed NCT00250406 - Assessment of Drug-eluting Ureteral Stent on Bacterial Adherence and Biofilm Formation Phase 2
Terminated NCT02419339 - Early Infancy Ureteral Reimplantation for Distal Ureteral Obstruction
Completed NCT00301470 - Functional MR Urography Phase 4
Enrolling by invitation NCT05022199 - Use of SPY Fluorescent Angiography to Reduce Ureteroenteric Stricture Rate Following Urinary Diversion N/A
Enrolling by invitation NCT02160652 - Ureteral Reimplantation for the Treatment of Extrinsic Malignant Ureteral Obstruction N/A
Recruiting NCT01788865 - Efficacy and Safety of a Covered Self-expandable Dual-layered Metallic Mesh Stent (UVENTA) in Ureteral Obstruction Phase 4
Completed NCT02744430 - Mirabegron as Medical Expulsive Therapy (MET) for Ureteral Stones and Ureteral Stent Pain Phase 2
Completed NCT00169650 - Laparoscopic Pyeloplasty Registry and Database N/A
Completed NCT01542593 - Evaluating Ureteral Length Using Computed Tomography (CT) N/A
Completed NCT00166361 - Drainage of Malignant Extrinsic Ureteral Obstruction Using the Memokath Ureteral Stent N/A
Completed NCT00142064 - A Randomized Control Trial Comparing Single vs. Multiple Application of Lidocaine Analgesia Prior to Urethral Catheterization Procedures Phase 2
Completed NCT04695951 - Efficacy and Safety of Renalof® in the Removal of Calculi Smaller Than 10 mm Located in the Reno-Ureteral Tract Phase 2
Withdrawn NCT00199472 - Comparison of Dynamic Contrast Enhanced CT and Diuretic Renogram in The Evaluation of UPJO N/A